| Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection J Dyall, CM Coleman, T Venkataraman, MR Holbrook, J Kindrachuk, ... Antimicrobial agents and chemotherapy 58 (8), 4885-4893, 2014 | 749 | 2014 |
| Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis J Kindrachuk, B Ork, S Mazur, MR Holbrook, MB Frieman, D Traynor, ... Antimicrobial agents and chemotherapy 59 (2), 1088-1099, 2015 | 416 | 2015 |
| A broad-spectrum antiviral targeting entry of enveloped viruses MC Wolf, AN Freiberg, T Zhang, Z Akyol-Ataman, A Grock, PW Hong, J Li, ... Proceedings of the National Academy of Sciences 107 (7), 3157-3162, 2010 | 303 | 2010 |
| Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays J Dyall, E Postnikova, H Zhou, J Kindrachuk, RF Johnson, GG Olinger Jr, ... Journal of general virology 95 (3), 571-577, 2014 | 287 | 2014 |
| The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling M Laurent-Rolle, EF Boer, KJ Lubick, JB Wolfinbarger, AB Carmody, ... Journal of virology 84 (7), 3503-3515, 2010 | 281 | 2010 |
| Possible sexual transmission of Ebola virus—Liberia, 2015 A Christie, GJ Davies-Wayne, T Cordier-Lasalle, DJ Blackley, AS Laney, ... Morbidity and Mortality Weekly Report 64 (17), 479, 2015 | 246 | 2015 |
| Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus MF Saeed, AA Kolokoltsov, AN Freiberg, MR Holbrook, RA Davey PLoS pathogens 4 (8), e1000141, 2008 | 233 | 2008 |
| Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein S Bhardwaj, M Holbrook, RE Shope, ADT Barrett, SJ Watowich Journal of virology 75 (8), 4002-4007, 2001 | 180 | 2001 |
| Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding YE Wang, A Park, M Lake, M Pentecost, B Torres, TE Yun, MC Wolf, ... PLoS pathogens 6 (11), e1001186, 2010 | 171 | 2010 |
| Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography AN Freiberg, MB Sherman, MC Morais, MR Holbrook, SJ Watowich Journal of virology 82 (21), 10341-10348, 2008 | 167 | 2008 |
| Kyasanur forest disease MR Holbrook Antiviral research 96 (3), 353-362, 2012 | 165 | 2012 |
| Broadly neutralizing antibodies target the coronavirus fusion peptide C Dacon, C Tucker, L Peng, CCD Lee, TH Lin, M Yuan, Y Cong, L Wang, ... Science 377 (6607), 728-735, 2022 | 164 | 2022 |
| Historical perspectives on flavivirus research MR Holbrook Viruses 9 (5), 97, 2017 | 164 | 2017 |
| Defining the risk of SARS-CoV-2 variants on immune protection MM DeGrace, E Ghedin, MB Frieman, F Krammer, A Grifoni, A Alisoltani, ... Nature 605 (7911), 640-652, 2022 | 153 | 2022 |
| Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine JE Blaney, A Marzi, M Willet, AB Papaneri, C Wirblich, F Feldmann, ... PLoS pathogens 9 (5), e1003389, 2013 | 153 | 2013 |
| Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection AN Freiberg, MN Worthy, B Lee, MR Holbrook Journal of General Virology 91 (3), 765-772, 2010 | 148 | 2010 |
| Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus DE Volk, DWC Beasley, DA Kallick, MR Holbrook, ADT Barrett, ... Journal of Biological Chemistry 279 (37), 38755-38761, 2004 | 138 | 2004 |
| T-705 (favipiravir) inhibition of arenavirus replication in cell culture M Mendenhall, A Russell, T Juelich, EL Messina, DF Smee, AN Freiberg, ... Antimicrobial agents and chemotherapy 55 (2), 782-787, 2011 | 132 | 2011 |
| Single-particle cryo-electron microscopy of Rift Valley fever virus MB Sherman, AN Freiberg, MR Holbrook, SJ Watowich Virology 387 (1), 11-15, 2009 | 132 | 2009 |
| Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses JE Blaney, C Wirblich, AB Papaneri, RF Johnson, CJ Myers, TL Juelich, ... Journal of virology 85 (20), 10605-10616, 2011 | 127 | 2011 |
